Menu Close

Consumer Safety: Pfizer recalls 4.2m tablets of Nurtec ODT prescription drugs over risk of poisoning

RTT News

*The pharmaceutical company discloses the affected tablets manufactured and distributed across the United States are in a non-child-resistant blister card packaged with name of the product, dosage strength, NDC number and expiration date

Emmanuel Akosile | ConsumerConnect

Biohaven Pharmaceuticals of New Haven, Connecticut, United States (US), and Pfizer of New York are recalling about 4.2 million Nurtec ODT (rimegepant) orally disintegrating tablets.

ConsumerConnect gathered the packaging of the prescription drugs is not child resistant, posing a risk of poisoning to consumers. It is a prescription medicine used in adults for the: acute treatment of migraine attacks with or without aura. preventive treatment of episodic migraine.

However, no incidents or injuries are reported, according to agency report.

This current recall involves prescription drugs Nurtec ODT 75 mg orally disintegrating tablets sold in cartons containing one blister card of 8 tablets, all dates through 6/2026 and NDC number 72618-3000-2.

The tablets are in a non-child-resistant blister card packaged in a carton that includes the name of the product, dosage strength, NDC number and expiration date.

It further explained that the dosage strength and expiration date are printed or stamped on the blister card.

The tablets, manufactured in the US, were sold at pharmacies nationwide as a prescribed medicine from December 2021, through March 2023.

The prices of the product are varied based on health insurance terms and other factors.

In regard to what to do in addressing the defect, Pfizer urged consumers should immediately place the recalled product out of the sight and reach of children and contact the company for a free child resistant pouch to store the product.

The pharmaceutical manufacturer said

once the product is secured, consumers could continue to use it as directed.

Consumers may contact Pfizer on (800) 879-3477 Monday through Friday 9 a.m. to 7 p.m. (ET) or online at for more information.

Kindly Share This Story




Kindly share this story